Oxidative damage pathways in relation to normal tissue injury

British Journal of Radiology

Volumn 80, Issue SPEC. ISS. 1, 2007, Pages

  Zhao, W ^a   Diz, D I ^a   Robbins, Mike E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN II ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ANTIINFLAMMATORY ACTIVITY; BRAIN INJURY; CELL FUNCTION; CELL INTERACTION; CHRONIC INFLAMMATION; CONFERENCE PAPER; HUMAN; HYPOTHESIS; IONIZING RADIATION; IRRADIATION; KIDNEY INJURY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; RADIATION FIBROSIS; RADIATION INJURY; RADIATION NECROSIS; RADIATION PNEUMONIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TISSUE INJURY;

ANGIOTENSIN II; ANIMALS; HUMANS; INFLAMMATION; OXIDATIVE STRESS; RADIATION INJURIES; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 34948897918     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/18237646     Document Type: Conference Paper

References (125)

1. Withers HR, Peters LJ, Kogelnik HS. The pathobiology of late effects in irradiation. In: Meyn RE, Withers HR, editors. Radiation biology in cancer research. New York, NY: Raven Press, 1980:439-48.
2. Rubin P, Casarett GW. Clinical radiation pathology as applied to curative radiotherapy. Cancer 1968;22:767-78.
3. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 1995;33:99-109.
4. Denham JW, Hauer-Jensen M. The radiotherapeutic injury - a complex "wound". Radiother Oncol 2002;63:129-45.
5. Moulder J, Robbins MEC, Cohen EP, Hopewell JW, Ward WF. Pharmacologic modification of radiation-induced late normal tissue injury. In: Mittal BB, Purdy JA, Ang KK, editors. Radiation therapy. Norwell, MA: Kluwer, 1998: 129-51.
6. Stone HB, McBride WH, Coleman CN. Modifying normal tissue damage postirradiation. Radiat Res 2002;157:204-23.
7. Dent P, Yacoub A, Confessa J, Caron R, Amorino G, Valerie K, et al. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res 2003;159:283-300.
8. Martin M, Lefaix JL, Delanian S. TGF-β1 and radiation fibrosis: a master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 2000;47:277-90.
9. Moulder JE. Post-irradiation approaches to treatment of radiation injuries in the context of radiological terrorism and radiation accidents: a review. Int J Radiat Biol 2004;80:3-10.
10. Robbins MEC, Zhao W. Chronic oxidative stress and radiation-induced late normal tissue injury: a review. Int J Radiat Biol 2004;80:251-59.
11. Fridovich I. Fundamental aspects of reactive oxygen species, or what's the matter with oxygen? Ann NY Acad Sci 1999;893:13-18.
12. Nordberg J, Arner ESJ. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001;31:1287-312.
13. Leigh GJ. Nomenclature of inorganic chemistry. Recommendations 1990. Oxford: Blackwell Scientific Publications.
14. Kuppusamy P, Zweier JL. Characterization of free radical generation by xanthine oxidase. Evidence for hydroxyl radical generation. J Biol Chem 1989;264:9880-4.
15. Baud L, Ardaillou R. Reactive oxygen species: production and role in the kidney. Am J Physiol Renal Fluid Electrolyte Physiol 1986;251:F765-6.
16. McIntyre M, Bohr DF, Dominiczak AF. Endothelial function in hypertension. Hypertension 1999;34:539-45.
17. Babior BM. NADPH oxidase: an update. Blood 1999;93:1464-76.
18. Griendling K, Sorescu D, Ushio-Fukai M. NADPH oxidase: role in cardiovascular biology and disease. Circ Res 2000;86:494-501.
19. Weisiger RA, Fridovich I. Mitochondrial superoxide dismutase: site of synthesis and intramitochondrial localization. J Biol Chem 1973;248:4793-6.
20. Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci USA 1982;79:7634-8.
21. Rhee SG, Chang TS, Bae YS, Lee SR, Kang SW. Cellular regulation by hydrogen peroxide. J Am Soc Nephrol 2003;14(Suppl. 3):S211-15.
22. Massey V. Activation of molecular oxygen by flavins and flavoproteins. J Biol Chem 1994;269:22459-62.
23. Winterbourn CC, Vissers MC, Kettle AJ. Myeloperoxidase. Curr Opin Hematol 2000;7:53-8.
24. -.), superoxide dismutases, and related matters. J Biol Chem 1997;272:18515-17.
25. Fujii J, Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 2002;7:123-30.
26. Wood ZA, Poole LB, Karplus PA. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 2003;300:650-3.
27. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
28. Gross SS, Wolin MS. Nitric oxide: Pathophysiological mechanisms. Annu Rev Physiol 1995;57:737-69.
29. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994;298:249-58.
30. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001;357:593-615.
31. Ignarro LJ. Heam-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling. Pharmacol Toxicol 1990;67:1-7.
32. Kanner J, Harel S, Granit R. Nitric oxide as an antioxidant. Arch Biochem Biophys 1991;289:130-6.
33. Wink DA, Mitchell JB. Chemical biology of nitric oxide: insights into regulatory, cytotoxic and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998;25:434-56.
34. Forman HJ, Torres M, Fukuto J. Redox signaling. Mol Cell Biochem 2002;234-35:49-62.
35. Nathan C. Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J Clin Invest 2003;111:769-78.
36. Pfeilschifter J, Eberhardt W, Beck K-F. Regulation of gene expression by nitric oxide. Pflungers Arch 2001;442:479-86.
37. Allen RG, Tresini M. Oxidative stress and gene regulation. Free Radic Biol Med 2000;28:463-99.
38. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2001;82:47-95.
39. Riley PA. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol 1994;65:27-33.
40. Spitz DR, Azzam EI, Li JJ, Gius D. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastat Rev 2004;23:311-22.
41. Morales A, Miranda M, Sanchez-Reyes A, Biete A, Fernandez-Checa JC. Oxidative damage of mitochondrial and nuclear DNA induced by ionizing radiation in human hepatoblastoma cells. Int J Radiat Oncol Biol Phys 1998;42:191-203.
42. Lyng FM, Seymour CB, Mothersill C. Oxidative stress in cells exposed to low levels of ionizing radiation. Biochem Soc Trans 2001;29:350-3.
43. Leach JK, Van Tuyle G, Lin P-S, Schmidt-Ullrich R, Mikkelsen RB. Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Res 2001;61:3894-901.
44. Yoo J-C, Pae H-O, Choi B-M, Kim W-I, Kim J-D, Kim Y-M, et al. Ionizing radiation potentiates the induction of nitric oxide synthase by interferon-γ (IFN-γ) or IFN-γ and lipopolysaccharide in BNL CL.2 murine embryonic liver cells: role of hydrogen peroxide. Free Radic Biol Med 2000;28:390-6.
45. Leach JK, Black SM, Schmidt-Ullrich RK, Mikkelsen RB. Activation of constitutive nitric-oxide synthase activity is an early signaling event induced by ionizing radiation. J Biol Chem 2002;277:15400-06.
46. Mikkelsen RB, Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 2003;22:5734-54.
47. Clemens MR, Ladner C, Schmidt H, Ehninger G, Einsele H, Buhler E, et al. Decreased essential antioxidants and increased lipid hydroperoxides following high-dose radiochemotherapy. Free Radic Res Commun 1989;7:227-32.
48. Arterbery VE, Pryor WA, Jiang L, Sehnert SS, Foster WM, Abrams RA, et al. Breath ethane generation during clinical total body irradiation as a marker of oxygen-free-radical-mediated lipid peroxidation: a case study. Free Radic Biol Med 1994;17:569-76.
49. Ueda T, Toyoshima Y, Moritani T, Ri K, Otsuki N, Kushihashi T, et al. Protective effect of dipyridamole against lethality and lipid peroxidation in liver and spleen of the ddY mouse after whole-body irradiation. Int J Radiat Biol 1996;69:199-204.
50. Umegaki K, Sugisawa A, Shin SJ, Yamada K, Sano M. Different onsets of oxidative damage to DNA and lipids in bone marrow and liver in rats given total body irradiation. Free Radic Biol Med 2001;31:1066-74.
51. Lonergan PE, Martin DSD, Horrobin DF, Lynch MA. Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to γ-irradiation. J Biol Chem 2002;277:20804-11.
52. Nozaki Y, Hasegawa Y, Takeuchi A, Fan ZH, Nakashima I, Shimokata K. Nitric oxide as an inflammatory mediator of radiation pneumonitis in rats. Am J Physiol Lung Cell Mol Physiol 1997;272:L651-8.
53. Tsuji C, Shioya S, Hirota Y, Fukuyama N, Kurita D, Tanigaki T, et al. Increased production of nitrotyrosine in lung tissue of rats with radiation-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2000;278:L719-25.
54. Giaid A, Lehnert SM, Chehayeb B, Chehayeb D, Kaplan I, Shenouda G. Inducible nitric oxide synthase and nitroytrosine in mice with radiation-induced lung damage. Am J Clin Oncol 2003;26:E67-72.
55. Jack CIA, Cottier B, Jackson MJ, Cassapi L, Fraser WD, Hind CRK. Indicators of free radical activity in patients developing radiation pneumonitis. Int J Radiat Oncol Biol Phys 1996;34:149-54.
56. Beinert T, Binder D, Stuschke M, Torres RA, Oehm C, Fleischhacker M, et al. Oxidant-induced lung injury in anticancer therapy. Eur J Med Res 1999;4:43-53.
57. Beinert T, Binder D, Oehm C, Ziemer S, Priem F, Stuschke M, et al. Further evidence for oxidant-induced vascular endothelial growth factor up-regulation in the bronchoalveolar lavage fluid of lung cancer patients undergoing radio-chemotherapy. J Cancer Res Clin Oncol 2000;126:352-6.
58. Vujaskovic Z, Anscher MS, Feng Q-F, Rabbani ZN, Amin K, Samulski TS, et al. Radiation-induced hypoxia may perpetuate late normal tissue injury. Int J Radiat Oncol Biol Phys 2001;50:851-5.
59. Duranteau J, Chandel NS, Kulisz A, Zhao Z, Schumaker PT. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 1998;273:11619-24.
60. Killilea DW, Hester R, Balczon R, Babal P, Gillespie MN. Free radical production in hypoxic pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2000;279:L408-12.
61. Li C, Jackson R. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 2002;282:C227-41.
62. Kang SK, Rabbani ZN, Folz RJ, Golson ML, Huang H, Yu D, et al. Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury. Int J Radiat Oncol Biol Phys 2003;57:1056-66.
63. Monje ML, Mizumatsu S, Fike JR, Palmer T. Irradiation induced neural precursor-cell dysfunction. Nat Med 2002;8:955-61.
64. Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003;302:1760-5.
65. Fukuda H, Fukuda A, Zhu C, Korhonen L, Swanpalmer J, Hertzman S, et al. Irradiation-induced progenitor cell death in the developing brain is resistant to erythropoietin treatment and caspase inhibition. Cell Death Differ 2004;11:1166-78.
66. Limoli CL, Rola R, Giedzinski E, Mantha S, Huang T-T, Fike JR. Cell-density-dependent regulation of neural precursor cells function. Proc Natl Acad Sci USA 2004;101:16052-7.
67. Rola R, Sarkissian V, Obenaus A, Nelson GA, Otsuka S, Limoli CL, et al. High-LET radiation induces inflammation and persistent changes in markers of hippocampal neurogenesis. Radiat Res 2005;164:556-60.
68. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001;2:108-15.
69. Banisadr G, Queraud-Lesaux F, Boutterin MC, Pelaprat D, Zale B, Rostene W, et al. Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem 2002;81:257-69.
70. Tofilon PJ, Fike JR. The radioresponse of the central nervous system: a dynamic process. Radiat Res 2000;153:357-70.
71. Sawaya R, Rayford A, Kono S, Ang KK, Feng Y, Stephens LC, et al. Plasminogen activator inhibitor-1 in the pathogenesis of delayed radiation damage in rat spinal cord in vivo. J Neurosurg 1994;81:381-7.
72. Robbins MEC, Zhao W, Davis CS, Toyokuni S, Bonsib SM. Radiation-induced kidney injury: a role for chronic oxidative stress? Micron 2002;33:133-41.
73. Frank J, Pompella A, Biesalski HK. Histochemical visualization of oxidant stress. Free Radic Biol Med 2000;29:1096-105.
74. Kasai H, Nishimura S, Kurokawa Y, Hayashi Y. Oral administration of the renal carcinogen, potassium bromate, specifically produces 8- hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis 1987;8:1959-61.
75. Greenberger JS, Epperly MW, Gretton J, Jefferson M, Nie S, Bernarding M, et al. Radioprotective gene therapy. Curr Gene Ther 2003;3:183-95.
76. Moulder JE. Pharmacological intervention to prevent or ameliorate chronic radiation injuries. Semin Radiat Oncol 2003;2003:73-84.
77. Anscher MS, Vujaskovic Z. Mechanisms and potential targets for prevention and treatment of normal tissue injury after radiation therapy. Semin Oncol 2005;32(Suppl. 3):S86-91.
78. Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system- an endocrine and paracrine system. Endocrinology 2003;144:2179-83.
79. Klickstein LB, Kaempfer CE, Wintroub BU. The granulocyte-angiotensin system. Angiotensin I-converting enzyme activity of cathepsin G. J Biol Chem 1982;257:15042-6.
80. Schiller PW, Demassieux S, Boucher R. Substrate specificity of tonin from rat submaxillary gland. Circ Res 1976;39:629-32.
81. Baltaru O, Nishimura H, Hoffman S, Stoltenburg G, Haulica ID, Lippoldt A, et al. High levels of human chymase expression in the pineal and pituitary glands. Brain Res 1997;752:269-78.
82. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Processing of angiotensin peptides by NG108-15 neuroblastoma x glioma hybrid cell line. Peptides 1990;11:375-80.
83. Yamamoto K, Chappell MC, Brosnihan KB, Ferrario CM. In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension 1992;19:692-6.
84. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Conversion of angiotensin I to angiotensin-(1-7) by thimet oligopeptidase (EC 3.4.24.15) in vascular smooth muscle cells. J Vasc Biol Med 1995;5:129-37.
85. Santos RAS, Brosnihan KB, Jacobsen DW, DiCorleto P, Ferrario CM. Production of Ang-(1-7) by human vascular endothelium. Hypertension 1992;19(Suppl. II):II-56-61.
86. Wright JW, Harding JW. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory. Prog Neurobiol 2004;72:263-93.
87. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000;87:E1-9.
88. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000;275:33238-43.
89. Burrell LM, Johnston CI, Tikellis C, Cooper ME. ACE2, a new regulator of the renin-angiotensin system. TRENDS Endocrinol Metab 2004;15:166-9.
90. Kambayashi Y, Bhardan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, et al. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 1993;268:24543-6.
91. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven transmembrane receptors. J Biol Chem 1993;268:24539-42.
92. Chappell MC, Modrall JG, Diz DI, Ferrario CM. Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation. Contrib Nephrol 2004;143:77-89.
93. + currents involves an inhibitory G protein. Am J Physiol 1994;267:0289-97.
94. iα3 in the rat fetus. J Biol Chem 1996;271:15026-33.
95. Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000;35:1270-7.
96. Davisson RL. Physiological genomic analysis of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 2003;285:R498-511.
97. Bader M, Peters J, Baltatu O, Muller DN, Luft FC, Ganten D. Tissue renin-angiotensinogen systems: new insights from experimental animal models in hypertension research. J Mol Med 2001;79:76-102.
98. Mulrow PJ. The intrarenal renin angiotensin. Curr Opin Nephrol Hyperten 1993;2:41-4.
99. Chappell MC, Diz DI, Gallagher PE. The renin-angiotensin system and the exocrine pancreas. J Panc Online 2001;2:33-9.
100. Nielsen AH, Schauser KH, Poulsen K. The uteroplacental renin-angiotensin system. Placenta 2000;21:468-77.
101. Piepho RW. Overview of the angiotensin-converting enzyme inhibitors. Am J Health-Syst Pharm 2000;57:S3-7.
102. Basso N, Paglia N, Stella I, de Cavanagh EM, Ferder L, del Rosario Lores Arnaiz M, et al. Protective effect of the inhibition of the renin-angiotensin system on aging. Regul Pept 2005;128:247-52.
103. Kasper SO, Basso N, Kurnjek ML, Paglia N, Ferrario CM Ferder LF, et al. Divergent regulation of circulation and intra-renal renin-angiotensin systems in response to long-term blockade. Am J Nephrol 2005;25:335-41.
104. Tedesco MA, Ratti G, Di Salvo G, Natale F. Does the angiotensin II receptor antagonist losartan improve cognitive function? Drugs Aging 2002;19:723-32.
105. Molteni A, Moulder JE, Cohen EP, Ward WF, Fish BL, Taylor JM, et al. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int J Radiat Biol 2000;76:523-32.
106. Datta PK, Moulder JE, Fish BL, Cohen EP, Lianos EA. TGF-β1 production in radiation nephropathy: role of angiotensin II. Int J Radiat Biol 1999;75:473-9.
107. Robbins ME, Diz DI. Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. Int J Radiat Oncol Biol Phys. 2006;64:6-12.
108. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003;35:881-900.
109. Blume A, Herdegen T, Unger T. Angiotensin peptides and inducible transcription factors. J Mol Med 1999;77:339-57.
110. Ritz E, Haxsen V. Angiotensin II and oxidative stress: an unholy alliance. J Am Soc Nephrol 2003;14:2985-7.
111. Touyz RM, Tabet F, Schiffrin EL. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin Exp Pharmacol Physiol 2003;30:860-6.
112. Saavedra JM, Ando H, Armando I, Baiardi G, Bregonzio C, Juorio A, et al. Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists. Regul Pept 2005;128:227-38.
113. Black PH. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 2002;16:622-53.
114. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004;4:181-9.
115. phox binding: a role of Rac in NADPH oxidase activation. Biochem Biophys Res Commun 1999;263:118-22.
116. Li J-M, Shah A. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 2002;277:19952-60.
117. Griendling K, Minieri C, Ollerenshaw J, Alexander R. Angiotensin II stimulated NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-8.
118. Karlsson A, Dahlgren C. Assembly and activation of the neutrophil NADPH oxidase in granule membranes. Antioxid Redox Signal 2002;4:49-60.
119. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Res 2003;24:471-8.
120. Calka J, Block CH. Angiotensin-(1-7) and nitric oxide synthase in the hypothalamo-neuropophysial syste. Brain Bull 1993;30:677-85.
121. Kohara K, Brosnihan KB, Ferrario CM. Angiotensin-(1-7) in the spontaneously hypertensive rat. Peptides 1993;14:883-91.
122. Iyer SN, Chappell MC, Averill DB, Diz DI, Ferrario CM. Vasodepressor actions of Angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 1998;31:699-705.
123. Ferrario CM, Chappell MC. Novel angiotensin peptides. Cell Mol Life Sci 2004;61:2720-7.
124. Garcia-Espinosa MA, Gallagher PE, Ferrario CM, Ganten D, Diz DI. Neprilysin and ACE2 regulation during aging in rats with low brain angiotensinogen. Hypertension 2005;46:830.
125. Kasper SO, Carter CS, Ferrario CM, Ganten D, Ferder LF, Sonntag WE, et al. Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin system. Physiol Genomics 2004;23:311-17.